Table 1.

Result of the case–control comparison of the viral abundance for RA, SLE and MS

Viruses	RA (N case=111 and N control=111)			SLE (N case=47 and N control=201)			MS (N case=29 and N control=74)
	Effect size	SE	P	Effect size	SE	P	Effect size	SE	P
Autographiviridae	−0.051	0.293	0.86	0.257	0.338	0.45	−0.380	1.052	0.72
crAss-like phage	−0.476	0.173	0.0060**	−0.514	0.206	0.012*	0.425	0.488	0.38
Herelleviridae	−0.579	0.320	0.070	−0.109	0.311	0.73	1.730	1.278	0.18
Microviridae	0.155	0.231	0.50	0.265	0.279	0.34	0.729	0.781	0.35
Myoviridae	0.657	0.672	0.33	−0.753	0.858	0.38	−1.908	2.108	0.37
Phycodnaviridae	0.049	0.256	0.85	−0.513	0.273	0.060	−0.004	0.567	0.99
Podoviridae	−0.147	0.325	0.65	−0.947	0.330	0.0041**	0.893	1.041	0.39
Siphoviridae	−0.986	1.437	0.49	−3.710	1.487	0.013*	−0.667	3.417	0.85

*P<0.05, **P<0.01.

MS, multiple sclerosis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.